Real-world Effectiveness of Anlotinib in Combination with PD-1 Inhibitors As Second-Line or Later Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma.
Journal of Clinical Oncology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要